Log In or Create Account
Resistance Mutations
Podcasts
Key Slides
Question of the Week
CROI
RWHAP Clinical Conference
Donate
Contact
CME Courses
HIV In-Person and Virtual Courses
Current On-Demand Courses
About Courses
CME Webinars
Upcoming Webinars
Current On-Demand Webinars
DEA-Compliant CME Resource Center For HIV Clinicians
About Webinars
Dialogues
Upcoming IAS–USA Dialogues
On-Demand Dialogues
About Dialogues
Topics In Antiviral Medicine
Current Issues for CME
Previous Issues
TAM
Policies and Practices
Permission Request Form
Did You Know?
FAQs
Fellow/Student Resources
Fellow/Student Resources
IAS-USA Guidelines
On-Demand Webcasts
Research Collaborations
Additional Resources
About
Mission
Scientific Leadership Board
Core Faculty
Staff
CME
Funding Information
Careers
Website Policies
Governance
FAQs
Menu
Elana S. Rosenthal, MD
Elana S. Rosenthal, MD
University of Maryland
Resistance Mutations
Podcasts
Key Slides
Question of the Week
CROI
RWHAP Clinical Conference
Donate
Contact
CME Courses
HIV In-Person and Virtual Courses
Current On-Demand Courses
About Courses
CME Webinars
Upcoming Webinars
Current On-Demand Webinars
DEA-Compliant CME Resource Center For HIV Clinicians
About Webinars
Dialogues
Upcoming IAS–USA Dialogues
On-Demand Dialogues
About Dialogues
Topics In Antiviral Medicine
Current Issues for CME
Previous Issues
TAM
Policies and Practices
Permission Request Form
Did You Know?
FAQs
Fellow/Student Resources
Fellow/Student Resources
IAS-USA Guidelines
On-Demand Webcasts
Research Collaborations
Additional Resources
About
Mission
Scientific Leadership Board
Core Faculty
Staff
CME
Funding Information
Careers
Website Policies
Governance
FAQs
Practice Question of the Week
September 18, 2023: Drug-Drug Interactions in Patients With HIV and Alcohol Use Disorder
A 34-year-old man presents to care after a recent hospital admission for acute alcohol intoxication, complicated by a fall and pneumonia. He is diagnosed with alcohol use disorder. He has an 8-year history of HIV, with an HIV RNA level of 3000 copies/mL and he reports difficulty adhering to his antiretroviral therapy. Which of the following is the most appropriate pharmacotherapy for his alcohol use disorder?
A. Acamprosate, taken by mouth 3 times daily
B. Disulfiram, taken by mouth daily
C. Extended-release injectable naltrexone, administered every 4 weeks
D. None of the above
Register for the Webinar
View Archived Questions
Leave Feedback
Subscribe
CLOSE
